These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3692443)
1. Greater efficiency of human growth hormone therapy in children below five years of age with growth hormone deficiency. A 5-year follow-up study. Josefsberg Z; Bauman B; Pertzelan A; Laron Z Horm Res; 1987; 27(3):126-33. PubMed ID: 3692443 [TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey. Job JC; Chaussain JL; Garnier P; Rolland A; Joab N Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186 [TBL] [Abstract][Full Text] [Related]
3. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503 [TBL] [Abstract][Full Text] [Related]
4. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study. Ranke MB; Guilbaud O Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451 [TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Sulmont V; Brauner R; Fontoura M; Rappaport R Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044 [TBL] [Abstract][Full Text] [Related]
6. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Lanes R; Gunczler P Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907 [TBL] [Abstract][Full Text] [Related]
7. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone. Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053 [TBL] [Abstract][Full Text] [Related]
8. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Zenaty D; Garel C; Limoni C; Czernichow P; Léger J Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449 [TBL] [Abstract][Full Text] [Related]
9. Age as a determinant of the impact of growth hormone therapy on predicted adult height. Hochberg Z; Leiberman E; Landau H; Koren R; Zadik Z Clin Endocrinol (Oxf); 1994 Sep; 41(3):331-5. PubMed ID: 7955440 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190 [TBL] [Abstract][Full Text] [Related]
11. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy. Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002 [TBL] [Abstract][Full Text] [Related]
12. Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency. Ranke M; Weber B; Bierich JR Eur J Pediatr; 1979; 132(4):221-38. PubMed ID: 574823 [TBL] [Abstract][Full Text] [Related]
13. Early initiation of growth hormone treatment: influence on final height. Vanderschueren-Lodeweyckx M; Van den Broeck J; Wolter R; Malvaux P Acta Paediatr Scand Suppl; 1987; 337():4-11. PubMed ID: 3324638 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW). Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553 [TBL] [Abstract][Full Text] [Related]
15. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Grumbach MM; Bin-Abbas BS; Kaplan SL Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672 [TBL] [Abstract][Full Text] [Related]
16. Recombinant growth hormone in children and adolescents with Turner syndrome. Cave CB; Bryant J; Milne R Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993 [TBL] [Abstract][Full Text] [Related]
17. Changes with growth hormone treatment in growth hormone deficient children. Ocal G; Berberoglu M; Akçurin S; Memioglu N; Ikinciogullari A Acta Paediatr Jpn; 1995 Feb; 37(1):7-11. PubMed ID: 7754771 [TBL] [Abstract][Full Text] [Related]
18. Transitory growth hormone deficiency successfully treated with human growth hormone. Trygstad O Acta Endocrinol (Copenh); 1977 Jan; 84(1):11-22. PubMed ID: 576178 [TBL] [Abstract][Full Text] [Related]
19. Biosynthetic human growth hormone in the treatment of growth hormone deficiency. Holcombe JH; Conforti PM; Wong AC; Thompson RG; Draper MW Acta Paediatr Scand Suppl; 1990; 367():44-8. PubMed ID: 2220388 [TBL] [Abstract][Full Text] [Related]
20. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS. Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]